Ai Miyashiro

Tokushima, 7708503, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

A Pilot Study of A2NTX, a Novel Low-Molecular-Weight Neurotoxin Derived from Subtype A2 for Post-Stroke Lower Limb Spasticity: Comparison with OnabotulinumtoxinA.

A Pilot Study of A2NTX, a Novel Low-Molecular-Weight Neurotoxin Derived from Subtype A2 for Post-Stroke Lower Limb Spasticity: Comparison with OnabotulinumtoxinA.

Journal: Toxins

Published: September 05, 2022

Clinical Safety and Tolerability of A2NTX, a Novel Low-Molecular-Weight Neurotoxin Derived from Botulinum Neurotoxin Subtype A2, in Comparison with Subtype A1 Toxins.

Clinical Safety and Tolerability of A2NTX, a Novel Low-Molecular-Weight Neurotoxin Derived from Botulinum Neurotoxin Subtype A2, in Comparison with Subtype A1 Toxins.

Journal: Toxins

Published: October 04, 2021

Increased IP-10 production by blood-nerve barrier in multifocal acquired demyelinating sensory and motor neuropathy and multifocal motor neuropathy.

Increased IP-10 production by blood-nerve barrier in multifocal acquired demyelinating sensory and motor neuropathy and multifocal motor neuropathy.

Journal: Journal of neurology, neurosurgery, and psychiatry

Published: July 20, 2018

Epidemiology, symptoms, and pathogenesis of MMN

Epidemiology, symptoms, and pathogenesis of MMN

Journal: Nihon rinsho. Japanese journal of clinical medicine

Published: October 21, 2015

Are multifocal motor neuropathy patients underdiagnosed? An epidemiological survey in Japan.

Are multifocal motor neuropathy patients underdiagnosed? An epidemiological survey in Japan.

Journal: Muscle & nerve

Published: April 18, 2014

Increased proinflammatory cytokines in sera of patients with multifocal motor neuropathy.

Increased proinflammatory cytokines in sera of patients with multifocal motor neuropathy.

Journal: Journal of the neurological sciences

Published: February 07, 2014

Treatment of spasticity with botulinum toxin

Treatment of spasticity with botulinum toxin

Journal: Rinsho shinkeigaku = Clinical neurology

Published: December 03, 2013

DYT6 in Japan-genetic screening and clinical characteristics of the patients.

DYT6 in Japan-genetic screening and clinical characteristics of the patients.

Journal: Movement disorders : official journal of the Movement Disorder Society

Published: August 18, 2013

Sera from patients with multifocal motor neuropathy disrupt the blood-nerve barrier.

Sera from patients with multifocal motor neuropathy disrupt the blood-nerve barrier.

Journal: Journal of neurology, neurosurgery, and psychiatry

Published: August 09, 2013

Update of multifocal motor neuropathy

Update of multifocal motor neuropathy

Journal: Nihon rinsho. Japanese journal of clinical medicine

Published: June 20, 2013

A case of cerebral air embolism developed during pleural lavage

A case of cerebral air embolism developed during pleural lavage

Journal: Rinsho shinkeigaku = Clinical neurology

Published: March 09, 2013

Treatment and indication of botulinum toxin type A for limb spasticity - can we break the 6 months barrier?

Treatment and indication of botulinum toxin type A for limb spasticity - can we break the 6 months barrier?

Journal: Rinsho shinkeigaku = Clinical neurology

Published: December 01, 2012

Showing 1-12 of 14

Last Updated: 09/26/2026